Search - tctmd.com

Displaying 61 - 80 of 163

Sort: Relevancy | Date

Presentation TCT 2017

Diagnosis and Treatment Options for RV Shock

Presenter: Vladimir Dzavik, Navin K. Kapur, James A. Goldstein

October 31, 2017

Presentation TCT 2017

Cardiogenic Shock in the Elderly: Rational Treatment Suggestions

Presenter: Vladimir Dzavik, Navin K. Kapur, Jose M. de la Torre Hernandez

October 31, 2017

Presentation TCT 2017

New Strategies for a Chronic Scenario: Combinative Approaches

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Amit N. Patel

October 31, 2017

Presentation TCT 2017

Cardiac Arrest With Cardiogenic Shock: Specific Management Considerations

Presenter: Vladimir Dzavik, Navin K. Kapur, Christian M. Spaulding

October 31, 2017

Presentation TCT 2017

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Timothy D. Henry

October 31, 2017

Presentation TCT 2017

New Targets: Heart Failure With Preserved Ejection Fraction

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Eugenio Cingolani

October 31, 2017

Presentation TCT 2017

Acute Cardiogenic Shock: The Case for First-line Use of ECMO

Presenter: Vladimir Dzavik, Navin K. Kapur, Robb Kociol

October 31, 2017

Presentation TCT 2017

Acute Cardiogenic Shock: The Case for First-line Use of Impella

Presenter: Vladimir Dzavik, Navin K. Kapur, Mark B. Anderson

October 31, 2017

Presentation TCT 2017

In Which Direction is Cell Based Heart Failure Therapy Headed?

Presenter: Francisco Fdez-Aviles, Emerson C. Perin

October 31, 2017

Presentation TCT 2017

Acute Cardiogenic Shock: The Case for First-line Use of IABP

Presenter: Vladimir Dzavik, Navin K. Kapur, David A Baran

October 31, 2017

Presentation TCT 2017

Synthesis of Randomized Trial and Registry Data for Devices in Cardiogenic Shock: What Is the Evidence for Efficacy?

Presenter: Vladimir Dzavik, Navin K. Kapur, Nicolas M. Van Mieghem

October 31, 2017

Presentation TCT 2017

Acute Cardiogenic Shock: Pathophysiology, Hemodynamics, and Treatment Goals

Presenter: Vladimir Dzavik, Navin K. Kapur, Holger Thiele

October 31, 2017

Presentation TCT 2017

Colombia Presents to Ukraine: Pulmonary Valvuloplasty and Concomitant LAD PCI

Presenter: Mohammad Al-Mutairi, Ahmed Magdy, Jorge Villegas

October 31, 2017

Presentation TCT 2017

Editorial Perspective: End-stage HF Treatment: Time for An Interventional Approach?

Presenter: Louis A. Cannon, Peter J. Fitzgerald, Juan F. Granada, Daniel Burkhoff

October 31, 2017

Presentation TCT 2017

Editorial Perspective: Device-based Neuromodulation and Interventional HF Therapy

Presenter: Louis A. Cannon, Peter J. Fitzgerald, Juan F. Granada, Emerson C. Perin

October 31, 2017

Presentation TCT 2017

Editorial Perspective: The Evolving Role of LVAD in Interventional HF

Presenter: Louis A. Cannon, Peter J. Fitzgerald, Juan F. Granada, Ileana L. Pina

October 31, 2017

Presentation TCT 2017

Soft Robotic Cardiac Assist Device for Heart Failure Patients (CorInnova)

Presenter: Louis A. Cannon, Peter J. Fitzgerald, Juan F. Granada, William C Altman

October 31, 2017

Presentation TCT 2017

Getting Surgical-like Results With Alcohol Septal Ablation

Presenter: Carey D. Kimmelstiel, Richard Smalling, Paul Sorajja

October 30, 2017

Presentation TCT 2017

Alcohol Septal Ablation - Learning Techniques Through Proctoring

Presenter: Carey D. Kimmelstiel, Richard Smalling, Srihari S. Naidu

October 30, 2017

Presentation TCT 2017

Building an HCM Program - Benchmarks for Centers of Excellence

Presenter: Carey D. Kimmelstiel, Richard Smalling, Sherif F. Nagueh

October 30, 2017

Advertisement

Diagnosis and Treatment Options for RV Shock

Cardiogenic Shock in the Elderly: Rational Treatment Suggestions

New Strategies for a Chronic Scenario: Combinative Approaches

Cardiac Arrest With Cardiogenic Shock: Specific Management Considerations

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

New Targets: Heart Failure With Preserved Ejection Fraction

Acute Cardiogenic Shock: The Case for First-line Use of ECMO

Acute Cardiogenic Shock: The Case for First-line Use of Impella

In Which Direction is Cell Based Heart Failure Therapy Headed?

Acute Cardiogenic Shock: The Case for First-line Use of IABP

Synthesis of Randomized Trial and Registry Data for Devices in Cardiogenic Shock: What Is the Evidence for Efficacy?

Acute Cardiogenic Shock: Pathophysiology, Hemodynamics, and Treatment Goals

Colombia Presents to Ukraine: Pulmonary Valvuloplasty and Concomitant LAD PCI

Editorial Perspective: End-stage HF Treatment: Time for An Interventional Approach?

Editorial Perspective: Device-based Neuromodulation and Interventional HF Therapy

Editorial Perspective: The Evolving Role of LVAD in Interventional HF

Soft Robotic Cardiac Assist Device for Heart Failure Patients (CorInnova)

Getting Surgical-like Results With Alcohol Septal Ablation

Alcohol Septal Ablation - Learning Techniques Through Proctoring

Building an HCM Program - Benchmarks for Centers of Excellence

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content